This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Eunkyung Lee: Innovator in Antibody Development
Introduction
Eunkyung Lee is a prominent inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on specific binding agents that have the potential to impact therapeutic applications.
Latest Patents
Eunkyung Lee holds 1 patent for his invention titled "Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof." This patent discloses specific binding agents, such as fully human antibodies, that bind to angiopoietin 1 and/or angiopoietin-2. The patent also includes heavy chain fragments, light chain fragments, and CDRs of the antibodies, as well as methods of making and using these antibodies.
Career Highlights
Eunkyung Lee is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to contribute to groundbreaking research and development in the field of antibodies.
Collaborations
Eunkyung Lee has collaborated with notable colleagues, including Thomas Charles Boone and Jonathan Daniel Oliner. These collaborations have further enhanced the research and development efforts within his team.
Conclusion
Eunkyung Lee's contributions to antibody development exemplify the innovative spirit of modern biotechnology. His patent on angiopoietin-targeting antibodies showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile